Assessment of Corneal Stiffness in Keratoconus After Crosslinking by Corvis ST and OCT.

December 6, 2021 updated by: Mohamed Mohamed Samir Elnoamany, Cairo University

Assessment of Corneal Stiffness Parameters in Keratoconus After Corneal Collagen Cross Linking Using Dynamic Scheimpflug Technology and Anterior Segment Optical Coherence Tomography.

Objectives:

  • Measurement of corneal stiffness parameters { Deformation Amlitude (DAR1), Integrated radius, Stress parameter (SP A1), Stress strain index (SSI) and Corvis biomechanical index (CBI) } in keratoconic corneas before and after 3 and 6 months CXL using Corvis ST.
  • Measurement of demarcation line depth using anterior segment OCT and correlate between corneal stiffness following CXL and demarcation line depth.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Background and Rationale:

Keratoconus is a progressive corneal degeneration resulting from noninflammatory thinning of the corneal stroma. Visual impairment typically commences in adolescence and progresses thereafter. Further increase in myopia, irregular astigmatism, and subepithelial scarring leads to visual impairment. Treatment modalities are based on refractive correction with spectacles or contact lenses to correct astigmatism and restore visual acuity. Such modalities do not stop ectatic progression and further visual deterioration, which ultimately necessitates corneal transplantation in 10% to 20% of patients.

Corneal collagen cross-linking (CXL) has emerged as a promising techniq;ue to slow or halt the progression of keratoconus. CXL leads to an increase in intra and interfibrillar covalent bonds by photosensitized oxidation and causes a biomechanical stabilization of the cornea.

Corneal visualization using dynamic Scheimpflug technology (Corvis ST, Oculus Optikger€ate GmbH) allows in vivo measurement of the corneal biomechanical deformation response to an applied air puff and is useful for evaluating the biomechanical response parameters of the cornea. It captures the dynamic corneal deformation caused by an air puff using an ultrahigh- speed camera that operates at a speed of greater than 4300 frames per second to capture a series of 140 sequential horizontal Scheimpflug images of the temporal-nasal cross section of the cornea. The consistency of the air puff has been shown and the spatial and temporal profiles have been characterized to allow calculation of the load on the cornea within the imaging window.

The Corvis ST enables the measurement of several parameters by analyzing the timing and patterns of deformation at the highest concavity as well as applanation during inward deformation (loading) and outward recovery (unloading). The original parameters have been reported to be influenced most strongly by intraocular pressure (IOP) as well as age and central corneal thickness (CCT). Recently, new corneal biomechanical parameters were introduced, including the Deformation Amplitude ratio at 1.0 mm (DAR1), Deformation Amplitude ratio at 2.0 mm (DAR2), Integrated radius, Stiffness Parameter at first applanation (SP A1), Ambrosio's Relational Thickness (ARTH) , Corbic Biomechanical index (CBI) and biomechanically corrected IOP (bIOP).

Laboratory studies have shown that the effective depth of CXL is confined to the anterior 300 μm of the cornea. Moreover, a stromal demarcation line between treated and untreated stroma was visible biomicroscopically at a depth of approximately 300 μm over the entire cornea after CXL treatment. This demarcation line was also evident on optical coherence tomography (OCT). The depth of this line has been postulated as an indirect measurement of cross-linking effectiveness.

Study Type

Interventional

Enrollment (Anticipated)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with documented progressive keratoconus within one year include any of the following:

A. ≥ 1.00 diopter increase in maximal keratometry (Kmax). B. ≥ 1.00 diopter increase in the manifest cylinder. C. ≥ 0.75 diopter increase in average of Kmax and Kmin (Kmean). D. ≥ 2% decrease in central thickness. E. ≥ 1.50 diopter increase in the central K power from baseline. F. ≥ 1.0 diopter increase in manifest spherical equivalent change (MRSE).

  • All patients have minimal corneal stromal thickness 400 μm before UVA irradiation.

Exclusion Criteria:

  • Patients with corneal rings.
  • Advanced keratoconus with corneal scarring.
  • History of herpetic keratitis and severe corneal infection.
  • Pregnancy or breastfeeding.
  • The use of rigid contact lens¬es for more than 4 weeks before the baseline evaluation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring changes in corneal stiffness parameters in keratoconus after CXL by Corvis ST which measures corneal stiffness parameters.
Time Frame: Before crosslinknig procedure and after 3, 6 months using Corvis ST.
Measurement of changes in corneal stiffness parameters { Deformation Amplitude (DAR1), Integrated radius, Stress parameter (SP A1), Stress strain index (SSI) and Corvis biomechanical index (CBI) } before and after crosslinking procedure to measure corneal stiffness.
Before crosslinknig procedure and after 3, 6 months using Corvis ST.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring demarcation line depth in microns by anterior segment OCT. in keratoconus after CXL with demarcation line depth in microns by anterior segment OCT.
Time Frame: After 3 and 6 months using anterior segment OCT
Measurement of demarcation line depth in the cornea in microns using anterior segment OCT which gives an indicator to corneal stiffness after crosslinking procedure.
After 3 and 6 months using anterior segment OCT

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mohamed Fakhry, MD, Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2022

Primary Completion (Anticipated)

January 1, 2023

Study Completion (Anticipated)

February 1, 2023

Study Registration Dates

First Submitted

October 19, 2021

First Submitted That Met QC Criteria

December 6, 2021

First Posted (Actual)

December 16, 2021

Study Record Updates

Last Update Posted (Actual)

December 16, 2021

Last Update Submitted That Met QC Criteria

December 6, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MD-80-2021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Keratoconus

Clinical Trials on Corvis ST (dynamic Scheimpflug technology)

3
Subscribe